Colorectal cancer kills more Americans than all other forms of cancer but one. More than 140,000 people were diagnosed with the disease last year.
Fortunately, help appears to be on the way. Zaltrap, a drug recently approved by federal regulators, produces a “statistically significant improvement in overall survival,” according to a new study published in the Journal of Clinical Oncology.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
